BiotechTube
Aelius Biotech

Aelius Biotech

London, United Kingdom· Est.
aeliusbiotech.co.uk
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Aelius Biotech is a specialized contract research organization (CRO) providing advanced gastrointestinal modeling services. Its core innovation is a mucus-enabled 3D gut model, which offers improved physiological relevance for testing orally delivered therapeutics and nutraceuticals. The company serves pharmaceutical, biotechnology, and food/beverage clients, helping them make data-driven decisions to de-risk development and guide human trials. Founded in 2020, it is a private, likely early-revenue stage company with a strong scientific leadership team.

OncologyImmunology

Technology Platform

Proprietary mucus-enabled 3D in vitro gut models designed to simulate human gastrointestinal physiology for assessing digestion, absorption, and local tolerability of orally delivered products.

Opportunities

Growing demand for predictive, human-relevant models to reduce drug development failures and replace animal testing provides a strong market tailwind.
Expansion into new geographic markets and verticals (e.g., consumer health, animal health) represents significant growth potential.

Risk Factors

Faces competition from other advanced in vitro model developers and must continually prove its platform's superior predictive validity.
Revenue is dependent on the cyclical R&D spending of client industries, and scalability of its bespoke service model presents an operational challenge.

Competitive Landscape

Competes with other specialized CROs offering organoid or organ-on-a-chip services, as well as traditional in vitro testing labs. Differentiation is claimed through the unique integration of a functional mucus layer, aiming for greater physiological relevance in GI modeling.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →